Long COVID
Top in ID: Paxlovid does not reduce long COVID risk; oral antibiotics safe in transplants
Paxlovid, an oral antiviral approved by the FDA in May 2023, did not reduce the risk for long COVID among vaccinated, nonhospitalized patients who received it within a month of their first SARS-CoV-2 infection, a study showed.
Vaccination reduces long COVID risk in children, study shows
COVID-19 vaccination reduces the risk for long COVID in children, according to findings from a study of more than 1 million children published in Pediatrics.
Paxlovid may not reduce risk for long COVID, study shows
Paxlovid did not reduce the risk for long COVID among vaccinated, nonhospitalized people who received it within a month of their first SARS-CoV-2 infection, a study showed.
COVID-19, long COVID and the rheumatologist with Leonard Calabrese, DO
What should rheumatologists know about what we've learned about COVID-19 and long COVID in 2023? Hosted by Dr. Leonard Calabrese.
This year’s top COVID-19 stories in pulmonology
Healio Pulmonology has compiled the top news on COVID-19 posted in 2023.
‘Long flu’ not as severe as long COVID but both need attention, experts say
Similar to SARS-CoV-2, which can cause long COVID, people hospitalized with influenza are at an increased risk for health issues long after they have cleared the infection, according to a study.
'Mysterious and sometimes debilitating': The complexity of managing long COVID
Long COVID can be difficult for primary care physicians to manage, but they are in a unique position to provide the best care for the condition, according to experts.
Highlights from ACR Convergence 2023
In this episode of Meeting Mic, we bring you Healio’s top headlines from ACR Convergence 2023.
MRIs reveal brain microstructure changes in people with long COVID
A novel MRI technique showed brain microstructure changes in people who have had COVID-19, and it traced long COVID symptoms to specific networks of the brain, according to a study.
Q&A: Hyperbaric oxygen therapy led to ‘significant cognitive improvement’ in long COVID
A study published recently in Nature found that hyperbaric oxygen therapy led to positive results for cognition and functionality for those with long COVID.